Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)
1993 ◽
Vol 71
(11)
◽
pp. 909-915
◽
2006 ◽
Vol 97
(4)
◽
pp. 466-471
◽
2003 ◽
Vol 41
(6)
◽
pp. 316
◽
1981 ◽
Vol 133
(2)
◽
pp. 197-204
◽
2000 ◽
Vol 20
(1)
◽
pp. 66
◽
1999 ◽
Vol 341
(6)
◽
pp. 410-418
◽
2003 ◽
Vol 1
(1)
◽
pp. 33-53
◽
2002 ◽
Vol 162
(9)
◽
pp. 993
◽